On November 28, 2023, AIM ImmunoTech Inc. announced that it will convene its upcoming 2023 annual meeting of stockholders as planned on December 1, 2023, and would then adjourn proceedings, without conducting any other business, until December 29, 2023. The Company stated that the purpose of the adjournment is to provide the Delaware Court of Chancery with sufficient time to issue a ruling with respect to the litigation brought against the Company and its directors by a member of a group of individuals who are seeking to nominate 3 candidates for election to the Company?s 4-person Board of Directors.